Benefit of ?-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention

14.01.20141524
Objective ?-blockers are the standard treatment for myocardial infarction (MI) based on evidence from the pre-thrombolytic era.

A Randomised Controlled Trial of Catheter Ablation Versus Medical Treatment of Atrial Fibrillation in Heart Failure (THE CAMTAF TRIAL)

13.01.20141587
Does restoration of sinus rhythm by catheter ablation improve outcomes in patients with atrial fibrillation and congestive heart failure?

Atrial Fibrillation and the Risk of Myocardial Infarction

10.01.20141623
What is the risk of incident myocardial infarction associated with atrial fibrillation?

Prognostic significance of prolonged PR interval in the general population

09.01.20141544
Prolonged PR interval, or first degree AV block, has been traditionally regarded as a benign electrocardiographic finding in healthy individuals, until recent studies have suggested that it may be associated with increased mortality and morbidity.

Artificial Heart With Norwegian Sensor

30.12.20131652
France is going to test an artificial heart on patients. The heart will contain a Norwegian pressure sensor.

Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis

27.12.20131305
This study aimed to produce a pooled estimate of risk of mortality from cardiovascular disease in patients with gout.

Heart failure in pregnant women with cardiac disease: data from the ROPAC

26.12.20131444
Heart failure (HF) is one of the most important complications in pregnant women with heart disease, causing maternal and fetal mortality and morbidity.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.